Clever Leaves Holdings Inc. (CLVR)
OTCMKTS: CLVR · Delayed Price · USD
3.170
-0.130 (-3.94%)
Jun 14, 2024, 1:16 PM EDT - Market closed

Company Description

Clever Leaves Holdings Inc. operates in the botanical cannabinoid and nutraceutical industries.

The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment cultivates, extracts, manufactures, commercializes, and distributes cannabinoid products comprising cannabis flowers, cannabidiol isolates, full spectrum and standardized extracts, and dry smokable flowers internationally.

The Non-Cannabinoid segment formulates, manufactures, markets, sells, distributes, and commercializes nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States.

It also produces extracted products, including isolates, crude oil extracts, and oral solutions; and tetrahydrocannabinol flowers.

The company serves retail distributors, pharmaceutical and cannabis companies, and pharmacies. Clever Leaves Holdings Inc. was founded in 2017 and is based in Tocancipá, Colombia.

Clever Leaves Holdings Inc.
Clever Leaves Holdings logo
Country Colombia
Founded 2016
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 296
CEO Andres Fajardo

Contact Details

Address:
Bodega 19-b Parque Industrial Tibitoc Ph
Tocancipa - Cundinamarca, F8 251017
Colombia
Phone 561-634-7430
Website cleverleaves.com

Stock Details

Ticker Symbol CLVR
Exchange OTCMKTS
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001819615
CUSIP Number 186760104
ISIN Number CA1867602031
SIC Code 2834

Key Executives

Name Position
Andres Fajardo Co-Founder, Chief Executive Officer and Director
Henry R. Hague III Chief Financial Officer
Julian Wilches Chief Regulatory Officer
Gustavo Escobar Chief Operating Officer
Marta Pinto Leite General Counsel and Corporate Secretary
Andrew Miller Head of Business Development
Camilo Bohorquez Head of Colombia
Caroline Kliess Managing Director of Germany
Jackie Keshner Investor Relations Executive

Latest SEC Filings

Date Type Title
May 21, 2024 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
May 16, 2024 15-12G Securities registration termination
May 15, 2024 SC 13D General statement of acquisition of beneficial ownership
May 8, 2024 EFFECT Notice of Effectiveness
May 6, 2024 S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
May 6, 2024 S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
May 6, 2024 S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
May 6, 2024 POS AM Post-Effective amendments for registration statement
May 6, 2024 25 Filing
Apr 26, 2024 8-K Current Report